https://ph-ksp.com/upfront-triple-combination-therapy-with-selexipag-insights-from-a-real-world-cohort-in-chinese-patients-with-pulmonary-arterial-hypertension-frontiers-in-cardiovascular-medicine-may-21-2026/ 2026-06-23T06:03:17Z PULMONARY HYPERTENSION en Upfront triple combination therapy with selexipag: insights from a real world cohort in Chinese patients with pulmonary arterial hypertension, Frontiers in Cardiovascular Medicine, May 21, 2026 2026-06-23T06:03:16Z Blog